Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Ending Cash Balance (2023 - 2026)

Updated

Translational Development Acquisition's Ending Cash Balance came in at $85,877 for Q2 2026, up 143.6% from $35,255 a year earlier and up 248.7% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) Ending Cash Balance (2023 - 2026) Analysis & Trends

For FY2025, Translational Development Acquisition's Ending Cash Balance was $29,787, down 93.2% from FY2024.

  • Going back by year, Ending Cash Balance was $438,174 in FY2024 and $2,021 in FY2023.
  • The Q2 2026 figure represents the highest quarterly Ending Cash Balance since Q1 2025.
  • Year-over-year, Ending Cash Balance increased in 1 of the last five quarters, with an average decline of 33.5%.
  • Business Quant data shows TDACU's Ending Cash Balance at $24,630 (Q1 2026), $29,787 (Q4 2025) and $47,150 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 85,877.00
Mar 31, 2026 24,630.00
Dec 31, 2025 29,787.00
Sep 30, 2025 47,150.00
Jun 30, 2025 35,255.00
Mar 31, 2025 206,600.00
Dec 31, 2024 438,174.00
Sep 30, 2024 224,038.00
Jun 30, 2024 72,021.00
Dec 31, 2023 2,021.00
API Access

Translational Development Acquisition Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=TDACU&period=max&api_key=YOUR_API_KEY